Other names NFC-1, NS-105, LAM-105
Fasoracetam is reported by some to improve focus and even induce "flow". But what does the science say about its efficacy for these purposes? Read on to find out.
This nootropic has no healthy human placebo-controlled studies that meet our inclusion criteria. Negative side effects can occur if used carelessly, so make sure you’re aware of the risks of Fasoracetam.
Read about the effects of Fasoracetam in relation to the amount of evidence we've found
Can fasoracetam help you focus better?
In a study  published in the journal Nature, Fasoracetam was found to reduce symptoms of ADHD in adolescents with specific gene variants.
The beneficial effects that were seen in this study are not necessarily going to transfer to healthy humans. It is not certain that your attention or focus would improve by use of fasoracetam in doses between 50 and 800mg over 5 weeks as it was used in this study. There are several reasons why this is the case:
- The tests used in the study to measure symptoms of ADHD are not measures only of focus, but of hyperactivity, response inhibition, and other aspects of the psychiatric condition as well
- Beneficial cognitive effects from a substance in people with a disorder are often thanks to the restoration of cognitive performance to levels closer to baseline, not an enhancement of performance to levels above baseline
- The effects were found in children, not in adults. If you are an adult, this is yet another reason to take these findings with a grain of salt
With those caveats in mind, let's conclude. Fasoracetam may work to enhance your focus, or maybe it won't. We simply don't have the science necessary to know whether it enhances cognitive performance in healthy humans yet.
If you want to understand the cognitive and affective effects of fasoracetam, you can read reviews and reports by people who have used it in the frequently asked questions section below.
The legality and side effects of Fasoracetam
Frequently asked questions about Fasoracetam
Studies conducted on the effects of Fasoracetam in healthy humans
Last updated Saturday, June 10, 2023